Literature DB >> 32259054

Toward Defining the Pharmacophore for Positive Allosteric Modulation of PTH1 Receptor Signaling by Extracellular Nucleotides.

Brandon H Kim1, Fang I Wang1, Alexey Pereverzev1, Peter Chidiac1, S Jeffrey Dixon1.   

Abstract

The parathyroid hormone 1 receptor (PTH1R) is a Class B G-protein-coupled receptor that is a target for osteoporosis therapeutics. Activated PTH1R couples through Gs to the stimulation of adenylyl cyclase. As well, β-arrestin is recruited to PTH1R leading to receptor internalization and MAPK/ERK signaling. Previously, we reported that the agonist potency of PTH1R is increased in the presence of extracellular ATP, which acts as a positive allosteric modulator of PTH signaling. Another nucleotide, cytidine 5'-monophosphate (CMP), also enhances PTH1R signaling, suggesting that ATP and CMP share a moiety responsible for positive allostery, possibly ribose-5-phosphate. Therefore, we examined the effect of extracellular sugar phosphates on PTH1R signaling. cAMP levels and β-arrestin recruitment were monitored using luminescence-based assays. Alone, ribose-5-phosphate had no detectable effect on adenylyl cyclase activity in UMR-106 rat osteoblastic cells, which endogenously express PTH1R. However, ribose-5-phosphate markedly enhanced the activation of adenylyl cyclase induced by PTH. Other sugar phosphates, including glucose-1-phosphate, glucose-6-phosphate, fructose-6-phosphate, and fructose-1,6-bisphosphate, also potentiated PTH-induced adenylyl cyclase activation. As well, some sugar phosphates enhanced PTH-induced β-arrestin recruitment to human PTH1R heterologously expressed in HEK293H cells. Interestingly, the effects of glucose-1-phosphate were greater than those of its isomer glucose-6-phosphate. Our results suggest that phosphorylated monosaccharides such as ribose-5-phosphate contain the pharmacophore for positive allosteric modulation of PTH1R. At least in some cases, the extent of modulation depends on the position of the phosphate group. Knowledge of the pharmacophore may permit future development of positive allosteric modulators to increase the therapeutic efficacy of PTH1R agonists.
Copyright © 2019 American Chemical Society.

Entities:  

Year:  2019        PMID: 32259054      PMCID: PMC7088899          DOI: 10.1021/acsptsci.8b00053

Source DB:  PubMed          Journal:  ACS Pharmacol Transl Sci        ISSN: 2575-9108


  36 in total

Review 1.  Exercise as an anabolic stimulus for bone.

Authors:  Charles H Turner; Alexander G Robling
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

Review 2.  Localised GPCR signalling as revealed by FRET biosensors.

Authors:  Michelle L Halls
Journal:  Curr Opin Cell Biol       Date:  2018-11-22       Impact factor: 8.382

3.  Determining and understanding the control of glycolysis in fast-growth tumor cells. Flux control by an over-expressed but strongly product-inhibited hexokinase.

Authors:  Alvaro Marín-Hernández; Sara Rodríguez-Enríquez; Paola A Vital-González; Fanny L Flores-Rodríguez; Marina Macías-Silva; Marcela Sosa-Garrocho; Rafael Moreno-Sánchez
Journal:  FEBS J       Date:  2006-05       Impact factor: 5.542

Review 4.  Allostery and Biased Agonism at Class B G Protein-Coupled Receptors.

Authors:  Denise Wootten; Laurence J Miller; Cassandra Koole; Arthur Christopoulos; Patrick M Sexton
Journal:  Chem Rev       Date:  2016-04-04       Impact factor: 60.622

Review 5.  Physiological Bone Remodeling: Systemic Regulation and Growth Factor Involvement.

Authors:  Jawed A Siddiqui; Nicola C Partridge
Journal:  Physiology (Bethesda)       Date:  2016-05

Review 6.  Heterotrimeric G proteins in the control of parathyroid hormone actions.

Authors:  Murat Bastepe; Serap Turan; Qing He
Journal:  J Mol Endocrinol       Date:  2017-05       Impact factor: 5.098

Review 7.  G-protein-coupled receptors signalling at the cell nucleus: an emerging paradigm.

Authors:  Fernand Gobeil; Audrey Fortier; Tang Zhu; Michela Bossolasco; Martin Leduc; Michel Grandbois; Nikolaus Heveker; Ghassan Bkaily; Sylvain Chemtob; David Barbaz
Journal:  Can J Physiol Pharmacol       Date:  2006 Mar-Apr       Impact factor: 2.273

8.  Sustained cyclic AMP production by parathyroid hormone receptor endocytosis.

Authors:  Sébastien Ferrandon; Timothy N Feinstein; Marian Castro; Bin Wang; Richard Bouley; John T Potts; Thomas J Gardella; Jean-Pierre Vilardaga
Journal:  Nat Chem Biol       Date:  2009-08-23       Impact factor: 15.040

9.  Novel genetically encoded biosensors using firefly luciferase.

Authors:  Frank Fan; Brock F Binkowski; Braeden L Butler; Peter F Stecha; Martin K Lewis; Keith V Wood
Journal:  ACS Chem Biol       Date:  2008-06-20       Impact factor: 5.100

10.  Ecto-protein kinases and phosphatases: an emerging field for translational medicine.

Authors:  Garif Yalak; Yigal H Ehrlich; Bjorn R Olsen
Journal:  J Transl Med       Date:  2014-06-12       Impact factor: 5.531

View more
  1 in total

Review 1.  Endosomal parathyroid hormone receptor signaling.

Authors:  Karina A Peña
Journal:  Am J Physiol Cell Physiol       Date:  2022-08-01       Impact factor: 5.282

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.